Pyoderma gangrenosum arising during treatment of psoriasis with adalimumab: Effectiveness of ustekinumab

Australas J Dermatol. 2017 Nov;58(4):e270-e271. doi: 10.1111/ajd.12545. Epub 2017 Jun 28.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adalimumab / adverse effects*
  • Arthritis, Psoriatic / drug therapy
  • Dermatologic Agents / adverse effects*
  • Dermatologic Agents / therapeutic use
  • Female
  • Humans
  • Middle Aged
  • Pyoderma Gangrenosum / chemically induced*
  • Pyoderma Gangrenosum / drug therapy*
  • Ustekinumab / therapeutic use*

Substances

  • Dermatologic Agents
  • Ustekinumab
  • Adalimumab